Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Open-Angle Glaucoma or Ocular Hypertension”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00527501
What this trial is testing

IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-angle GlaucomaOcular Hypertension
Alcon Research 136
Early research (Phase 1)Study completedNCT02622334
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO5093151 in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT).

Who this might be right for
Glaucoma
Hoffmann-La Roche 45
Not applicableActive Not RecruitingNCT05035394
What this trial is testing

Swedish Microinvasive Glaucoma Surgery Study (SMIGS)

Who this might be right for
Open Angle GlaucomaCataractKahook Dual Blade Glide+3 more
Umeå University 120
Large-scale testing (Phase 3)Study completedNCT01895972
What this trial is testing

Long-Term Safety of Latanoprostene Bunod Ophthalmic Solution 0.024% in Japanese Subjects With OAG or OHT

Who this might be right for
GlaucomaOcular Hypertension
Bausch & Lomb Incorporated 130
Testing effectiveness (Phase 2)Study completedNCT07168902
What this trial is testing

Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Glaucoma
Bausch & Lomb Incorporated 252
Large-scale testing (Phase 3)Study completedNCT00061529
What this trial is testing

A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Alcon Research
Testing effectiveness (Phase 2)Study completedNCT01707381
What this trial is testing

BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
Ocular HypertensionOpen Angle Glaucoma
Bausch & Lomb Incorporated 25
Early research (Phase 1)Study completedNCT00767793
What this trial is testing

A Placebo-Controlled Study of INS117548 Ophthalmic Solution in Subjects With Glaucoma (P08650)

Who this might be right for
Glaucoma
Merck Sharp & Dohme LLC 84
Not applicableStudy completedNCT00823043
What this trial is testing

A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs

Who this might be right for
Open-angle GlaucomaOcular Hypertension
Vistakon Pharmaceuticals 103
Not applicableStudy completedNCT01628614
What this trial is testing

Intraocular Pressure (IOP) Reduction in Newly Diagnosed Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 4,812
Post-approval studies (Phase 4)Study completedNCT00761995
What this trial is testing

Safety and Efficacy of Brinzolamide Dosed TID With Dorzolamide Dosed TID in Reducing Intraocular Pressure in Patients With Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
GlaucomaOcular Hypertension
Alcon Research 200
Large-scale testing (Phase 3)Study completedNCT00760539
What this trial is testing

Safety and Efficacy of Travoprost/Timolol BAC-free

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Alcon Research 87
Post-approval studies (Phase 4)Study completedNCT00140049
What this trial is testing

A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma

Who this might be right for
Glaucoma, Open AngleOcular Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 238
Post-approval studies (Phase 4)Study completedNCT01471158
What this trial is testing

Patient Preference Comparison of AZARGA Versus COSOPT in Patients With Glaucoma

Who this might be right for
Glaucoma
Alcon Research 120
Post-approval studies (Phase 4)Study completedNCT01594970
What this trial is testing

A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH)

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 800
Large-scale testing (Phase 3)Study completedNCT01342094
What this trial is testing

DE-111 Against Timolol Ophthalmic Solution 0.5%

Who this might be right for
Open Angle GlaucomaOcular Hypertension
Santen Pharmaceutical Co., Ltd. 166
Large-scale testing (Phase 3)Study completedNCT00872651
What this trial is testing

Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-angle GlaucomaOcular Hypertension
Alcon Research 242
Post-approval studies (Phase 4)Study completedNCT01155219
What this trial is testing

Safety, Efficacy Assessment of Geltim LP® 1 mg/g in Ocular Hypertensive or Glaucomatous Patients.

Who this might be right for
Glaucoma
Laboratoires Thea 150
Early research (Phase 1)Study completedNCT01215786
What this trial is testing

Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 50
Large-scale testing (Phase 3)Study completedNCT02822742
What this trial is testing

A Study Assessing the Safety and Efficacy of DE-117 in Subjects With POAG or OH Who Are Non-/Low-responders to Latanoprost: FUJI Study

Who this might be right for
Primary Open Angle Glaucoma or Ocular Hypertension
Santen Pharmaceutical Co., Ltd. 26
Next Page